• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮间质转化:对乳腺癌干细胞和耐药性的影响。

Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.

机构信息

Institute of Genetic Medicine, Newcastle University, International Centre for Life, Central Parkway, Newcastle-upon-Tyne NE1 3BZ, UK.

Northern Institute for Cancer Research, Newcastle University, 3rd Floor William Leech Building, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK.

出版信息

Cancer Treat Rev. 2014 Apr;40(3):341-8. doi: 10.1016/j.ctrv.2013.09.008. Epub 2013 Sep 15.

DOI:10.1016/j.ctrv.2013.09.008
PMID:24090504
Abstract

There is increasing interest in cancer stem cells (CSCs) and their role in cancer progression. Recently, CSCs have been identified in brain, skin, and intestinal tumors and it has been suggested that these CSCs are responsible for tumor growth and metastasis. In breast cancer fatality is often due to the development of metastatic disease (MBC). Almost 30% of early breast cancer patients eventually develop MBC and in 90% of these multi-drug resistance (MDR) occurs. This could be attributed to the presence of breast cancer stem cells (BCSCs). Epithelial-to-mesenchymal transition (EMT) is a process known to contribute to metastasis in cancer and it is mainly characterized by loss of E-cadherin expression. The TGF-β signaling pathway has an established role in promoting EMT by down-regulating E-cadherin via a number of transcription factors, such as Twist, Snail and Slug. EMT has also been reported to produce cells with stem cell-like properties. Definition of the exact molecular mechanisms that are involved in the generation of stem cells through EMT could lead to the identification of new potential therapeutic targets and enable the development of more efficient strategies for particular patient groups. In this review we discuss what is known about the relationship between EMT, BCSCs and MDR.

摘要

人们对癌症干细胞(CSC)及其在癌症进展中的作用越来越感兴趣。最近,已经在脑、皮肤和肠道肿瘤中鉴定出了 CSC,并有人提出这些 CSC 负责肿瘤的生长和转移。在乳腺癌中,死亡率通常是由于转移性疾病(MBC)的发展。近 30%的早期乳腺癌患者最终会发展为 MBC,其中 90%会发生多药耐药(MDR)。这可能归因于乳腺癌干细胞(BCSC)的存在。上皮-间充质转化(EMT)是一种已知的促进癌症转移的过程,其主要特征是 E-钙粘蛋白表达的丧失。TGF-β 信号通路通过许多转录因子(如 Twist、Snail 和 Slug)下调 E-钙粘蛋白,在促进 EMT 方面发挥着既定作用。EMT 也被报道会产生具有干细胞样特性的细胞。明确参与 EMT 产生干细胞的具体分子机制,可以为确定新的潜在治疗靶点提供依据,并为特定患者群体开发更有效的策略。在这篇综述中,我们讨论了 EMT、BCSC 和 MDR 之间的关系。

相似文献

1
Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.上皮间质转化:对乳腺癌干细胞和耐药性的影响。
Cancer Treat Rev. 2014 Apr;40(3):341-8. doi: 10.1016/j.ctrv.2013.09.008. Epub 2013 Sep 15.
2
Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.上皮-间充质转化在原位至浸润性基底样乳腺癌的进展过程中增加。
Hum Pathol. 2013 Nov;44(11):2581-9. doi: 10.1016/j.humpath.2013.07.003. Epub 2013 Sep 20.
3
3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.3,5,4'-三甲氧基二苯乙烯,白藜芦醇的天然甲氧基类似物,通过下调 PI3K/Akt 和 Wnt/β-catenin 信号级联以及逆转上皮-间充质转化,抑制乳腺癌细胞的侵袭性。
Toxicol Appl Pharmacol. 2013 Nov 1;272(3):746-56. doi: 10.1016/j.taap.2013.07.019. Epub 2013 Aug 3.
4
Breast cancer stem cells, EMT and therapeutic targets.乳腺癌干细胞、上皮-间质转化与治疗靶点。
Biochem Biophys Res Commun. 2014 Oct 10;453(1):112-6. doi: 10.1016/j.bbrc.2014.09.069. Epub 2014 Sep 26.
5
Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells.上皮-间充质转化在人类甲状腺癌细胞中引发癌症干细胞的产生。
Int J Oncol. 2013 Jul;43(1):113-20. doi: 10.3892/ijo.2013.1913. Epub 2013 Apr 22.
6
EMT in breast cancer stem cell generation.EMT 在乳腺癌干细胞生成中的作用。
Cancer Lett. 2013 Sep 10;338(1):63-8. doi: 10.1016/j.canlet.2012.05.014. Epub 2012 May 22.
7
An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells.IL6-STAT3 环路通过诱导人乳腺癌细胞上皮-间质转化和癌症干细胞扩增介导对 PI3K 抑制剂的耐药性。
Biochem Biophys Res Commun. 2014 Oct 24;453(3):582-7. doi: 10.1016/j.bbrc.2014.09.129. Epub 2014 Oct 5.
8
Breast cancer stem cells: obstacles to therapy.乳腺癌干细胞:治疗的障碍。
Cancer Lett. 2013 Sep 10;338(1):57-62. doi: 10.1016/j.canlet.2012.04.023. Epub 2012 Apr 30.
9
Epithelial-to-mesenchymal transition and stem cells in endometrial cancer.子宫内膜癌中的上皮-间质转化和干细胞。
Hum Pathol. 2013 Oct;44(10):1973-81. doi: 10.1016/j.humpath.2013.04.009. Epub 2013 Jul 8.
10
[Epithelial-mesenchymal transition induces cancer stem cell generation in human thyroid cancer cells in vitro].上皮-间质转化在体外诱导人甲状腺癌细胞产生癌干细胞
Zhonghua Yi Xue Za Zhi. 2013 Apr 23;93(16):1261-5.

引用本文的文献

1
Lp‑PLA2 in the cancer landscape: From molecular mechanisms to therapeutic potential (Review).癌症领域中的脂蛋白磷脂酶A2:从分子机制到治疗潜力(综述)
Int J Oncol. 2025 Nov;67(5). doi: 10.3892/ijo.2025.5793. Epub 2025 Aug 24.
2
Pentagalloyl Glucose from Suppresses the Epithelial-Mesenchymal Transition and Synergizes the Doxorubicin-Induced Anticancer and Anti-Migration Effects in Triple-Negative Breast Cancer.来自[具体来源未提及]的五没食子酰葡萄糖抑制三阴性乳腺癌中的上皮-间质转化,并协同阿霉素诱导的抗癌和抗迁移作用。
Pharmaceuticals (Basel). 2024 Dec 20;17(12):1729. doi: 10.3390/ph17121729.
3
Synthetic and Natural Inhibitors of Mortalin for Cancer Therapy.
用于癌症治疗的Mortalin的合成和天然抑制剂
Cancers (Basel). 2024 Oct 13;16(20):3470. doi: 10.3390/cancers16203470.
4
UGT1A7 altered HER2-positive breast cancer response to trastuzumab by affecting epithelial-to-mesenchymal transition: A potential biomarker to identify patients resistant to trastuzumab treatment.UGT1A7 通过影响上皮间质转化改变曲妥珠单抗治疗 HER2 阳性乳腺癌的反应:一种潜在的生物标志物,用于识别对曲妥珠单抗治疗耐药的患者。
Cancer Gene Ther. 2024 Oct;31(10):1525-1535. doi: 10.1038/s41417-024-00819-y. Epub 2024 Aug 10.
5
Epigenetic regulation of breast cancer metastasis.乳腺癌转移的表观遗传调控。
Cancer Metastasis Rev. 2024 Jun;43(2):597-619. doi: 10.1007/s10555-023-10146-7. Epub 2023 Oct 19.
6
Zinc Finger E-Box Binding Homeobox Family: Non-Coding RNA and Epigenetic Regulation in Gliomas.锌指E盒结合同源框家族:胶质瘤中的非编码RNA与表观遗传调控
Biomedicines. 2023 May 5;11(5):1364. doi: 10.3390/biomedicines11051364.
7
Molecular and Immunohistochemical Alterations in Breast Cancer Patients in Upper Egypt.埃及上埃及地区乳腺癌患者的分子与免疫组化改变
Rep Biochem Mol Biol. 2023 Jan;11(4):532-546. doi: 10.52547/rbmb.11.4.532.
8
Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management.乳腺癌细胞外囊泡:从生物学和功能到临床诊断和治疗管理。
Int J Mol Sci. 2023 Apr 13;24(8):7208. doi: 10.3390/ijms24087208.
9
Hypoxia-Driven TGFβ Modulation of Side Population Cells in Breast Cancer: The Potential Role of ERα.缺氧驱动的乳腺癌侧群细胞中转化生长因子β的调节:雌激素受体α的潜在作用
Cancers (Basel). 2023 Feb 9;15(4):1108. doi: 10.3390/cancers15041108.
10
Aspirin increases the efficacy of gemcitabine in pancreatic cancer by modulating the PI3K/AKT/mTOR signaling pathway and reversing epithelial‑mesenchymal transition.阿司匹林通过调节PI3K/AKT/mTOR信号通路和逆转上皮-间质转化来提高吉西他滨在胰腺癌中的疗效。
Oncol Lett. 2023 Feb 1;25(3):101. doi: 10.3892/ol.2023.13687. eCollection 2023 Mar.